Posts by Sandra Ansanay-Alex
Biped Robotics Supported By FIT With a Digital Growth Loan
Biped Robotics develops NOA, a harness to improve mobility for visually impaired people. The number of people with impaired vision is rising steadily, and now stands at 300 million worldwide, including 6 million blind people. For them, getting around independently is a daily challenge. Biped Robotics’ solution to this is NOA, a shoulder-worn harness…
Read MoreLemna Bio awarded a CHF 100’000 EPFL Innogrant
Lemna Bio – an EPFL startup hosted by Professor Dal Pararo’s Laboratory of Biomolecular Modeling – has been awarded a CHF 100,000 Innogrant by the jury at the EPFL Startup Launchpad. With ageing populations and chronic diseases on the rise, the demand for effective medicines and therapies has never been greater. Yet, for decades, drug development has…
Read MoreEBAMed raised EUR 1.6 Million
The Geneva-based company has just secured a further EUR 1.6 Million from CDP Venture Capital and the European Union. This brings the total amount raised in the series A financing round to EUR 16 Million. EBAMed, is a Geneva-Based start-up developing a guidance system for the non-invasive treatment of heart arrhythmias through Proton Therapy.…
Read MoreComphya Receives FDA IDE Approval to Initiate U.S. Clinical Trial for CaverSTIM
Comphya SA, a pioneering medical technology company based in canton of Vaud and the developer of CaverSTIM, the first implantable neuromodulator designed to treat erectile dysfunction, announced that the U.S. Food and Drug Administration (FDA) has granted Investigational Device Exemption (IDE) approval to initiate a clinical trial to evaluate CaverSTIM in the United States. …
Read MoreHelix Robotics receives CHF 150,000 from Venture Kick
Helix Robotics is developing the first commercial soft robot manipulator. By combining the safety of soft robotics with industrial precision, the EPFL spin-off aims to enhance automation in food handling and lab automation. The startup was financed with CHF 150,000 by Venture Kick, winning the third stage of the programme. Traditional robotic arms…
Read MoreGARDP supports the development of Debiopharm’s new potential treatment for gonorrhoea
The Global Antibiotic Research & Development Partnership (GARDP) and the Swiss-based global biopharmaceutical company Debiopharm have signed a memorandum of understanding to develop Debio 1453, a novel compound representing a new antibiotic class that targets Neisseria gonorrhoeae. Multidrug-resistant strains of N. gonorrhoeae have emerged globally, limiting treatment options and elevating this pathogen to…
Read MoreJuvion Health Sciences and Neuria supported by the FIT
FIT announces the granting of two Tech Seed loans worth CHF 100,000 each to two Swiss Health Valley start-ups: Juvion Health Sciences and Neuria. Juvion: maintaining the structure and function of movement circuits to improve mobility One in three people over the age of 60 is affected by reduced mobility. This decline in…
Read MoreAspivix raises 1.95 million euros via crowdfunding campaign
Aspivix, the Swiss start-up behind Carevix™, an innovative device designed to transform gynecological practices, recently launched a crowdfunding campaign that has already raised 1.9 million euros. The initiative aims to bring together a community committed to supporting a technology focused on women’s comfort and health. With 85 investors, the crowdfunding campaign, accessible on…
Read MoreDiverSsiTy SA: Therapy for Adolescents with Autism Spectrum Disorder (ASD)
DiverSsiTy SA leverages Mixed Reality (MR) and Artificial Intelligence (AI) to revolutionise mental health for people with Autism Spectrum Disorder (ASD). The company has developed a personalized therapeutic solution designed to enhance social, emotional, and proprioceptive skills in adolescents with high-functioning autism, ultimately improving their quality of life and social integration. Origins &…
Read MoreA CHF 2 Million Innosuisse Grant for Tune Insight
2025 is off to a groundbreaking start for Tune Insight, a leading EPFL spin-off specializing in privacy-preserving data collaboration solutions. The start-up secured a CHF 2 Million Innosuisse Grant to revolutionise Real-World Evidence (RWE) access for AI in pharma. Despite growing interest in using Real-World Evidence (RWE) to fuel AI innovation in healthcare, access…
Read More